SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-289955
Filing Date
2019-11-12
Accepted
2019-11-12 16:15:10
Documents
14
Period of Report
2019-11-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d77646d8k.htm   iXBRL 8-K 27372
2 EX-99.1 d77646dex991.htm EX-99.1 9072
6 GRAPHIC g77646img001.jpg GRAPHIC 3409
  Complete submission text file 0001193125-19-289955.txt   164406

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA halo-20191112.xsd EX-101.SCH 3071
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE halo-20191112_lab.xml EX-101.LAB 17375
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE halo-20191112_pre.xml EX-101.PRE 10954
8 EXTRACTED XBRL INSTANCE DOCUMENT d77646d8k_htm.xml XML 3236
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32335 | Film No.: 191209581
SIC: 2836 Biological Products, (No Diagnostic Substances)